Kamiya Biomedical Company

4,5-DIAMINOFLUORESCEIN DIACETATE;4,5-DIAMINOFLUORORESCEIN DIACETATE;5,6-DIAMINOFLUORESCEIN DIACETATE;2-(3,6-DIACETYLOXY-9H-XANTHEN-9-YL)-4,5-DIAMINO-BENZOIC ACID;DAF-2 DA;DAF-2 DA, CELL PERMEABLE;DAF-2 DIACETATE;5,6-Diaminofluorescein diacetat

N-ACETYL-ASP-GLU-VAL-ASP 7-AMIDO-4-TRIFLUOROMETHYLCOUMARIN;N-ACETYL-ASP-GLU-VAL-ASP-(7-AMINO-4-TRIFLUOROMETHYLCOUMARIN);N-ACETYL-ASP-GLU-VAL-ASP-7-AMINO-4-TRIFLUOROMETHYLCOUMARIN AFC;CASPASE 3 (APOPAIN) SUBSTRATE 1F, FLUOROGENIC;CASPASE-3 SUBSTRATE (AFC);CASPASE-3 SUBSTRATE VII, FLUOROGENIC;CASPASE-3 FLUOROGENIC SUBSTRATE;FLUOROGENIC CASPASE 3 SUBSTRATE AC-DEVD-AFC

DEVD-CHO;CPP32/APOPAIN INHIBITOR;CPP32/APOPAIN INHIBITOR, CELL-PERMEABLE;CASPASE 3 (APOPAIN) INHIBITOR 1;CASPASE-3 INHIBITOR I;CASPASE-3 INHIBITOR I, CELL-PERMEABLE;CASPASE-3 INHIBITOR;CASPASE-3 INHIBITOR (ALDEHYDE)

CASPASE 3 (APOPAIN) SUBSTRATE 1, CHROMOGENIC;CASPASE-3 SUBSTRATE VIII, WATER-SOLUBLE, COLORIMETRIC;CASPASE 3/CPP32 CHROMOGENIC SUBSTRATE;CASPASE-3 SUBSTRATE (CHROMOGENIC);CASPASE-3 SUBSTRATE I, COLORIMETRIC;CHROMOGENIC CASPASE 3 SUBSTRATE AC-DEVD-PNA;AC-ASP-GLU-VAL-ASP-PARANITROANILIDE;AC-ASP-GLU-VAL-ASP-PNA

Ac-Ile-Glu-Thr-Asp-PNA;219138-21-3;AC-IETD-PNA;(4S)-4-[[(2S,3S)-2-acetamido-3-methylpentanoyl]amino]-5-[[(2S,3R)-1-[[(2S)-3-carboxy-1-(4-nitroanilino)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-5-oxopentanoic acid;SCHEMBL4594304;Caspase-8 Chromogenic Substrate I;MFCD01318840;ZINC150341012;HY-120833;CS-0079281

N-ACETYL-LEU-GLU-HIS-ASP 7-AMIDO-4-TRIFLUOROMETHYLCOUMARIN;N-ACETYL-LEU-GLU-HIS-ASP-(7-AMINO-4-TRIFLUOROMETHYLCOUMARIN);N-ACETYL-LEU-GLU-HIS-ASP-7-AMINO-4-TRIFLUOROMETHYLCOUMARIN AFC;AC-LEU-GLU-HIS-ASP-7-AMINO-4-TRIFLUORO-METHYLCOUMARIN;AC-LEU-GLU-HIS-ASP-AFC;AC-LEHD-AFC;CASPASE-9 SUBSTRATE I, FLUOROGENIC;CASPASE 9 SUBSTRATE 1F, FLUOROGENIC

N-acetyl-Val-Ala-Asp-Ala;Acetyl-valyl-alanyl-aspartal;N-Acetyl-Val-Ala-Asp-al (AC-VAD-CHO);AC-VAD-CHO;AC-VAL-ALA-ASP-ALDEHYDE;AC-VAL-ALA-ASP-ALDEHYDE (PSEUDO ACID);AC-VAL-ALA-ASP-CHO;CASPASE INHIBITOR II

AC-VDVAD-AFC;AC-VAL-ASP-VAL-ALA-ASP-7-AMINO-4-TRIFLUORO-METHYLCOUMARIN;AC-VAL-ASP-VAL-ALA-ASP-AFC;CASPASE 2 (ICH-1) SUBSTRATE 1F, FLUOROGENIC;N-ACETYL-VAL-ASP-VAL-ALA-ASP-7-AMIDO-4-TRIFLUOROMETHYLCOUMARIN;BKQMJQIAIFEZJR-OIOUIRQFSA-N

CASPASE 2 SUBSTRATE, CHROMOGENIC;CASPASE-2 SUBSTRATE IV;CASPASE-2 SUBSTRATE IV, COLORIMETRIC;CASPASE 2 (ICH-1) SUBSTRATE 1, CHROMOGENIC;AC-VAL-ASP-GLN-GLN-ASP-PARANITROANILIDE;AC-VAL-ASP-GLN-GLN-ASP-PNA;AC-VAL-ASP-VAL-ALA-ASP-PARANITROANILIDE;AC-VAL-ASP-VAL-ALA-ASP-PNA

CASPASE-6 SUBSTRATE II, COLORIMETRIC;CASPASE-6 SUBSTRATE (CHROMOGENIC);CASPASE 6 (MCH2) SUBSTRATE 1, CHROMOGENIC;AC-VAL-GLU-ILE-ASP-PARANITROANILIDE;AC-VAL-GLU-ILE-ASP-PNA;AC-VEID-PNA;N-ACETYL-VAL-GLU-ILE-ASP-P-NITROANILIDE;N-ACETYL-VAL-GLU-ILE-ASP-P-NITROANILIDE PNA

CASPASE 1 (ICE) SUBSTRATE 2F, FLUOROGENIC;AC-YVAD-AFC;AC-TYR-VAL-ALA-ASP-7-AMINO-4-TRIFLUOROMETHYL COUMARIN;AC-TYR-VAL-ALA-ASP-AFC;N-Acetyl-Tyr-Val-Ala-Asp-(7-amino-4-trifluoromethylcoumarin);M.W. 719.67 C33H36F3N5O10;N-ACETYL-TYR-VAL-ALA-ASP 7-AMIDO-4-TRIFLUOROMETHYLCOUMARIN;CASPASE-1 SUBSTRATE XII, FLUOROGENIC

N-ACETYL-L-TYROSYL-L-VALYL-N-[(1S)-2-CARBOXYL-1-FORMYLETHYL]-L-ALANINAMIDE;N-ACETYL-TYR-VAL-ALA-ASP-CHO (ALDEHYDE);N-ACETYL-TYR-VAL-ALA-GLU-AL;N-AC-TYR-VAL-ALA-ASP-CHO;N-ACETYL-ALA-ALA-VAL-ALA-LEU-LEU-PRO-ALA-VAL-LEU-LEU-ALA-LEU-LEU-ALA-PRO-TYR-VAL-ALA-ASP-CHO (ALDEHYDE);TYR-VAL-ALA-ASP-CHO;YVAD-CHO;ICE INHIBITOR

AC-TYR-VAL-ALA-ASP-PNA;N-ACETYL-TYR-VAL-ALA-ASP-P-NITROANILIDE PNA;N-acetyl-tyr-val-ala-asp P-nitroanilide;REF DUPL: Ac-Tyr-Val-Ala-Asp-pNA;N-Acetyl-L-tyrosyl-L-valyl-L-alanyl-N-(4-nitrophenyl)-L-α-asparagine;CASPASE-1 SUBSTRATE IV, COLORIMETRIC;CASPASE-1 SUBSTRATE (CHROMOGENIC);CASPASE 1 (ICE) SUBSTRATE 2, CHROMOGENIC

PAN BETA-AMYLOID (AB-1) POLYCLONAL ANTIBODY;MONOCLONAL ANTI-BETA-AMYLOID;ANTI-BETA-AMYLOID PROTEIN;ANTI-BETA-AMYLOID RABBIT PAB;ANTI-BETA AMYLOID;ANTI-AMYLOID BETA-PEPTIDE;ANTI-AMYLOID, BETA;ANTI-ABETA

Immunoglobulin G1,anti-(human CD40 ligand) (human-mouse monoclonal IDEC-131 γ1-chain),disulfide with human-mouse monoclonal IDEC-131 κ-chain,dimer;IDEC 131;Toralizumab;anti-CD 154;anti-gp39;anti-CD 40L;E 6040;gp39 antibody;IDEC/Eisai;anti-CD 154 mAb

Oxacyclohexadeca-3,5,11,13-tetraen-2-one,8-hydroxy-16-[(1S,2R,3S)-2-hydroxy-1-methyl-3-[(2R,4R,5S,6R)-tetrahydro-2,4-dihydroxy-5-methyl-6-(1-methylethyl)-2H-pyran-2-yl]butyl]-3,15-dimethoxy-5,7,9,11-tetramethyl-,(3Z,5E,7R,8S,9S,11E,13E,15S,16R)-;Hygrolidin,21-O-de(3-carboxy-1-oxo-2-propenyl)-2-demethyl-2-methoxy-24-methyl-;Oxacyclohexadecane,hygrolidin deriv.;(3Z,5E,7R,8S,9S,11E,13E,15S,16R)-8-Hydroxy-16-[(1S,2R,3S)-2-hydroxy-1-methyl-3-[(2R,4R,5S,6R)-tetrahydro-2,4-dihydroxy-5-methyl-6-(1-methylethyl)-2H-pyran-2-yl]butyl]-3,15-dimethoxy-5,7,9,11-tetramethyloxacyclohexadeca-3,5,11,13-tetraen-2-one;Bafilomycin A1;Oxacyclohexadeca-3,5,11,13-tetraen-2-one,8-hydroxy-16-[2-hydroxy-1-methyl-3-[tetrahydro-2,4-dihydroxy-5-methyl-6-(1-methylethyl)-2H-pyran-2-yl]butyl]-3,15-dimethoxy-5,7,9,11-tetramethyl-,[7R-[3Z,5E,7R*,8S*,9S*,11E,13E,15S*,16R*[1S*,2R*,3S*(2R*,4R*,5S*,6R*)]]]-;(-)-Bafilomycin A1;NSC 381866

HUMAN BRAIN-DERIVED NEUROTROPHIC FACTOR;HUMAN BDNF;BDNF;BDNF (HUMAN);BNDF;BRAIN-DERIVED NEUROTROPHIC FACTOR;BRAIN DERIVED NEUROTROPHIC FACTOR, HUMAN;BRAIN DERIVED NEUROTROPHIC FACTOR, HUMAN, RECOMBINANT

TETRAHYDRO-4-METHYLENE-2-OCTYL-5-OXO-3-FURANCARBOXYLIC ACID;C75;4-METHYLENE-2-OCTYL-5-OXOTETRAHYDROFURAN-3-CARBOXYLIC ACID;trans-C 75 (trans-4-Methylene-2-octyl-5-oxo-tetrahydro-furan-3-carboxylic acid);(2R,3S)-4-METHYLIDENE-5-OXO-2-N-OCTYL-OXOLANE-3-CARBOXYLIC ACID;(2R*,3S*)-Tetrahydro-4-methylene-2-octyl-5-oxo-3-furancarboxylicacid;(2R,3S)-rel-Tetrahydro-4-Methylene-2-octyl-5-oxo-3-furancarboxylic Acid;trans-Tetrahydro-4-Methylene-2-octyl-5-oxo-3-furancarboxylic Acid

Z-LEU-LEU-TYR-FLUOROMETHYLKETONE;Z-LEU-LEU-TYR-FMK;Z-LLY-FMK;CALPAIN INHIBITOR1;CALPAIN INHIBITOR IV

Carbonic acid,(1R)-2-[12-[(2R)-2-(benzoyloxy)propyl]-3,10-dihydro-4,9-dihydroxy-2,6,7,11-tetramethoxy-3,10-dioxo-1-perylenyl]-1-methylethyl 4-hydroxyphenyl ester,stereoisomer;Perylene,carbonic acid deriv.;Calphostin C;UCN 1028C;Cladochrome E;PKF 115-584;125411-36-1